Dr. Steven Curley, lead researcher for the Kanzius Cancer Research Project says his team expects to present its research on treating cancer with radio frequency waves to the FDA at the end of summer.
Speaking from Baylor College of Medicine by phone, Dr. Curley said a former FDA employee and consultant on the project recommended in April that Industrial Sales and Mfg. make modifications to the Kanzius RF Machines developed here in Erie and recommended on additional test on pigs that more closely replicate the type of repeated lower dose treatments that would be done on human subjects.
"After looking at my data, they recommended one more clinical study, that's starting now and will take three to four months to complete, once that is complete we expect to make application for human trials to the FDA at the end of summer or in September," said Curley.
Dr. Curley commented on the Kanzius Foundation's decision to cease operation at the end of June. "We've got funding in place through the end of 2015," said Curley. "After that point we will need to switch over to different funding sources and we are working on that. The foundation fulfilled its mission to take my research to human trials and they did so masterfully," said Curley.
When asked if his personal legal issues over alleged electronic spying on his former wife's computer activities might stand in the way of presenting to the FDA, Curley simply said, "No." His case is expected to go to trial in Houston in June.